Contact us

Customer portfolio

Big pharma, biotechs & academics 

Big pharma, biotech & academic sector:
More than 250 customers worldwide have already chosen PX’Therapeutics


PX’Therapeutics has been steadily building its position as a CDMO leader in the European market since 2000. With more than 250 customers, 10 collaborative programs, and over 1000 R&D and clinical projects, our company has been able to meet the market’s rigorous requirements.


Check out the testimonials of some of our non-confidential customers and their reasons for a very high level of satisfaction with PX’ services.